SIMPHS 2 – Strategic Intelligence Monitor on Personal Health Systems – Update
Personal health systems (PHS) and remote patient monitoring and treatment (RMT) have the potential to change the way healthcare is provided by increasing quantity and quality of care. Back in 2009, the Strategic Intelligence Monitor on Personal Health Systems (SIMPHS) research began by analyzing the market for RMT within PHS from a supply perspective. The objective was to assess the current size and future growth perspectives of the RMT market, generating an understanding of the structure, innovation dynamics, types of market players involved, and strategies followed; the ultimate aim was identification of market drivers and barriers as well as areas for policy action.
Subsequent to the conclusion of the first phase (SIMPHS 1), which was conducted during 2010–2012, the scope of the investigation was expanded in order to complement the supply side with a demand side approach, focusing on needs, demands, and experiences made on PHS by healthcare producer units (such as hospitals, primary care centers, etc.), healthcare professionals, healthcare authorities, as well as patients, among others. In addition to RMT, telecare, mobile health (mHealth), and fitness/ wellness applications were included in the scope of the research and termed: integrated personal healthcare services (IPHS).
During this second phase (SIMPHS 2) a series of activities have been carried out so that:
- market developments could be assessed, updating the findings of SIMPHS 1 and identifying new trends and developments;
- patient/user demands could be assessed by online survey in 14 member states, providing insights on the use of information and communications technology (ICT) for health and impacts on policy;
- experiences made in selected EU member states with IPHS deployment could be analyzed, in order to identify drivers and barriers for mainstreaming telehealth and telecare;
- the state-of-the-art could be reviewed in terms of impact assessment, providing an overview of existing methodologies, their benefits, and drawbacks in assessing telehealth outcomes;
- an extrapolation framework could be identified, as well as key indicators to assess the impact of wider deployment of telehealth in Europe.
The current status of PHS and, more specifically, of the RMT market in Europe are described. The question about how these technologies can help deal with some of the challenges faced by the European healthcare delivery systems is addressed (i.e. higher pressure of demand through chronic diseases and demographic change, combined with diminishing resources for healthcare). The report identifies various barriers that prevent the full deployment of RMT in Europe, and provides a number of tentative policy options that aim specifically to foster EU-wide deployment of RMT/PHS.
The final report is available at: http://ftp.jrc.es/EURdoc/JRC71183.pdf